LAPIX is an immune system modulation company with 2 distinct therapeutic pipelines; LAPIX-IO and LAPIX-TI. LAPIX-IO replaces multiple checkpoint inhibitors with a single standalone product delivered orally. LAPIX-TI is an alternative to the wrecking ball approach of immunosuppressants. LAPIX-TI has applications in the treatment of auto-immune disorders as well as tolerance induction for gene therapy and enzyme replacement therapy.